Faculty Collaboration Database

Mary Eapen MBChB, MS

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

Member of the Cancer Center
Member of the Cardiovascular Research Center
Member of the Center for International Blood and Marrow Transplant Research (CIBMTR)

Send Message

Request Meeting

View Curriculum Vitae

Publications (233)

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy (Eapen M, Williams DA) Cytotherapy August 2026;28(8) SCOPUS ID: 2-s2.0-105041324675 08/01/2026 1 Citation

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy. (Eapen M, Williams DA) Cytotherapy 2026 Aug;28(8):102906 PMID: 42258965 SCOPUS ID: 2-s2.0-105041324675 06/08/2026

Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease. (Gupta AO, Sharma A, Frangoul H, Kanter J, Mapara MY, Dalal J, Alavi A, Jaroscak JJ, Ayala E, DiPersio JF, Ziga ED, Eapen M, Rifkin-Zenenberg S, Minella AC, Chen Y, Chesler S, Ambati S, Bowman TS, Habtemariam B, Joseney-Antoine M, Chockalingam PS, Lin L, Goyal S, Simon A, Thompson AA, Heeney MM, BEACON Investigators) N Engl J Med 2026 May 07;394(18):1824-1835 PMID: 41931046 SCOPUS ID: 2-s2.0-105038472540 04/03/2026 11 Citations

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy. (Sharma A, Kassim A, Thompson A, Williams DA, Liu HD, Boelens JJ, LaBelle JL, Tisdale J, de la Fuente J, Kanter J, Krishnamurti L, Pecker LH, Walters MC, Eapen M, Porteus M, Bhatia M, Soni S, Corbacioglu S, John TD, Cancio MI) Transplant Cell Ther 2026 Jul;32(7):778-791 PMID: 41905703 PMCID: PMC13041730 SCOPUS ID: 2-s2.0-105037818224 03/30/2026 3 Citations

Defying age: myth or reality? (Eapen M) Haematologica 2026 May 01;111(5):1520-1522 PMID: 41098108 PMCID: PMC13136824 SCOPUS ID: 2-s2.0-105038071160 10/16/2025

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease. (Kassim AA, Walters MC, Eapen M, Smith M, Logan BR, Solh M, McKinney C, Nieder M, Ross M, Kent M, Abusin GA, Mallhi K, Silva JG, Shaughnessy P, Kanter J, Haines H, Farah R, Khaled YA, Ritzau N, Mendizabal A, Abraham A, Bollard C, Cooke K, de la Fuente J, Hanna R, Horowitz MM, Jordan LC, Bakshi N, Krishnamurti L, Leifer E, Mahadeo KM, Shenoy S, Jones RJ, DeBaun MR, Brodsky RA) NEJM Evid 2025 Mar;4(3):EVIDoa2400192 PMID: 39998298 PMCID: PMC11932095 02/25/2025

Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History. (Eapen M, Malec LM, Armant MA, Johnson BD, Shi Q, Xu H, Du LM, Jerkins JH, Duffy LJ, Bushman FD, Lee C, Petrichenko A, Hematti P, Brazauskas R, Jobe SM, Hari PN, Wilcox DA) N Engl J Med 2025 Jan 23;392(4):412-414 PMID: 39842018 PMCID: PMC11756741 SCOPUS ID: 2-s2.0-85216608254 01/22/2025 12 Citations

Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. (Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier C, Jaroscak JJ, Bergmann S, Wong T, Kota V, Pace B, Lekakis LJ, Lulla P, Nickel RS, Kasow KA, Popat U, Smith W, Yu L, DiFronzo N, Geller N, Kamani N, Klings ES, Hassell K, Mendizabal A, Sullivan K, Neuberg D, Krishnamurti L) Blood Adv 2025 Mar 11;9(5):955-965 PMID: 39471440 PMCID: PMC11907447 SCOPUS ID: 2-s2.0-86000334110 10/29/2024 15 Citations

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. (John TD, Walters MC, Rangarajan HG, Rahim MQ, McKinney C, Bollard CM, Abusin G, Eapen M, Kassim AA, DeBaun MR) Blood Adv 2024 Dec 10;8(23):6055-6063 PMID: 39374573 PMCID: PMC11635641 SCOPUS ID: 2-s2.0-85212196584 10/08/2024 3 Citations

One's expectations for normality (Eapen M) Blood 3 October 2024;144(14):1469-1470 SCOPUS ID: 2-s2.0-85204711177 10/03/2024

One's expectations for normality. (Eapen M) Blood 2024 Oct 03;144(14):1469-1470 PMID: 39361302 SCOPUS ID: 2-s2.0-85204711177 10/03/2024

Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ) Eclinicalmedicine October 2024;76 SCOPUS ID: 2-s2.0-85202953543 10/01/2024 4 Citations

Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study. (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ) EClinicalMedicine 2024 Oct;76:102819 PMID: 39290639 PMCID: PMC11405822 SCOPUS ID: 2-s2.0-85202953543 09/18/2024 4 Citations

Choosing donors in clinical practice (Eapen M) Blood 18 July 2024;144(3):248-249 SCOPUS ID: 2-s2.0-85198150047 07/18/2024

Choosing donors in clinical practice. (Eapen M) Blood 2024 Jul 18;144(3):248-249 PMID: 39023876 SCOPUS ID: 2-s2.0-85198150047 07/18/2024

Immunosuppression with post-transplant cyclophosphamide for allogeneic hematopoietic cell transplantation. (Eapen M) Haematologica 2024 Jul 01;109(7):2024-2025 PMID: 38946648 PMCID: PMC11215355 SCOPUS ID: 2-s2.0-85197633211 07/01/2024 1 Citation

Navigating Treatment Options and Communication in Relapsed Pediatric AML. (Graff Z, Wachter F, Eapen M, Lehmann L, Cooper T) Am Soc Clin Oncol Educ Book 2024 Jun;44(3):e438690 PMID: 38862135 06/12/2024

Corrigendum to "Endpoint selection and evaluation in hematology studies" [Best Pract Res Clin Haematol 36 (2023) 101479]. (Brazauskas R, Eapen M, Wang T) Best Pract Res Clin Haematol 2024 Mar;37(1):101540 PMID: 38490768 SCOPUS ID: 2-s2.0-85185562266 03/16/2024

Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479] (Best Practice & Research Clinical Haematology (2023) 36(3), (S1521692623000403), (10.1016/j.beha.2023.101479)) (Brazauskas R, Eapen M, Wang T) Best Practice and Research Clinical Haematology March 2024;37(1) SCOPUS ID: 2-s2.0-85185562266 03/01/2024

Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. (Eapen M, Kou J, Andreansky M, Bhatia M, Brochstein J, Chaudhury S, Haight AE, Haines H, Jacobsohn D, Jaroscak J, Kasow KA, Krishnamurti L, Levine JE, Leung K, Margolis D, Yu LC, Horowitz MM, Kamani N, Walters MC, Shenoy S) Am J Hematol 2024 Apr;99(4):785-788 PMID: 38343182 PMCID: PMC10947844 SCOPUS ID: 2-s2.0-85185139592 02/12/2024 5 Citations

Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States. (Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A) Bone Marrow Transplant 2023 Dec;58(12):1400-1402 PMID: 37673983 PMCID: PMC11646697 SCOPUS ID: 2-s2.0-85170080925 09/07/2023 2 Citations

No impact of CD34⁺ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. (Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA) Bone Marrow Transplant 2023 Dec;58(12):1390-1393 PMID: 37666957 PMCID: PMC11221560 SCOPUS ID: 2-s2.0-85169665242 09/05/2023 2 Citations

Endpoint selection and evaluation in hematology studies (Brazauskas R, Eapen M, Wang T) Best Practice and Research Clinical Haematology September 2023;36(3) SCOPUS ID: 2-s2.0-85161313534 09/01/2023 1 Citation

Endpoint selection and evaluation in hematology studies. (Brazauskas R, Eapen M, Wang T) Best Pract Res Clin Haematol 2023 Sep;36(3):101479 PMID: 37611997 PMCID: PMC10979628 SCOPUS ID: 2-s2.0-85161313534 08/24/2023 1 Citation

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy. (Nakamura R, Patel BA, Kim S, Wong FL, Armenian SH, Groarke EM, Keesler DA, Hebert KM, Heim M, Eapen M, Young NS) Haematologica 2023 Dec 01;108(12):3298-3307 PMID: 37259612 PMCID: PMC10690917 SCOPUS ID: 2-s2.0-85171560866 06/01/2023 6 Citations

Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101. (Ramsey SD, Bansal A, Li L, O'Donnell PV, Fuchs EJ, Brunstein CG, Eapen M, Thao V, Roth JA, Steuten LMG) Transplant Cell Ther 2023 Jul;29(7):464.e1-464.e8 PMID: 37120135 PMCID: PMC10353308 SCOPUS ID: 2-s2.0-85160025736 04/30/2023 8 Citations

What causes aplastic anaemia? (Gale RP, Hinterberger W, Young NS, Gennery AR, Dvorak CC, Hebert KM, Heim M, Broglie L, Eapen M) Leukemia 2023 Jun;37(6):1191-1193 PMID: 37106162 PMCID: PMC10353698 SCOPUS ID: 2-s2.0-85153963425 04/28/2023 15 Citations

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. (Geerlinks AV, Scull B, Krupski C, Fleischmann R, Pulsipher MA, Eapen M, Connelly JA, Bollard CM, Pai SY, Duncan CN, Kean LS, Baker KS, Burroughs LM, Andolina JR, Shenoy S, Roehrs P, Hanna R, Talano JA, Schultz KR, Stenger EO, Lin H, Zoref-Lorenz A, McClain KL, Jordan MB, Man TK, Allen CE, Marsh RA) Blood Adv 2023 Jul 25;7(14):3725-3734 PMID: 37042921 PMCID: PMC10368780 SCOPUS ID: 2-s2.0-85183633571 04/13/2023 4 Citations

Reply to R. Meisel. (Eapen M, Brazaukas R) J Clin Oncol 2023 Jun 10;41(17):3273-3274 PMID: 37043706 PMCID: PMC10256417 SCOPUS ID: 2-s2.0-85163236843 04/13/2023

Effect of Autograft CD34⁺ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. (Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA) Transplant Cell Ther 2023 Jun;29(6):380.e1-380.e9 PMID: 36990222 PMCID: PMC10247464 SCOPUS ID: 2-s2.0-85153799554 03/30/2023 2 Citations

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE) Transplant Cell Ther 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023 70 Citations

What Causes Aplastic Anaemia: Results of Transplants from Genetically-Identical Twins. (Gale R, Hinterberger W, Young NS, Gennery A, Dvorak C, Hebert K, Heim M, Broglie L, Eapen M) Res Sq 2023 Feb 03 PMID: 36778326 PMCID: PMC9915784 02/14/2023

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. (Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM) J Clin Oncol 2023 Apr 20;41(12):2227-2237 PMID: 36623245 PMCID: PMC10448940 SCOPUS ID: 2-s2.0-85152619905 01/10/2023 54 Citations

To treat with curative intent or modify disease? (Eapen M) Blood 2023 Jan 05;141(1):4-5 PMID: 36602825 SCOPUS ID: 2-s2.0-85145307082 01/06/2023

To treat with curative intent or modify disease? (Eapen M) Blood 5 January 2023;141(1):4-5 SCOPUS ID: 2-s2.0-85145307082 01/05/2023

Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. (Krishnamurti L, Neuberg D, Sullivan KM, Smith S, Eapen M, Walters MC) Transplant Cell Ther 2023 Apr;29(4):217-221 PMID: 36270432 PMCID: PMC10539686 SCOPUS ID: 2-s2.0-85149958842 10/22/2022 8 Citations

Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022 2 Citations

Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022 2 Citations

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. (DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA) Lancet Haematol 2022 Sep;9(9):e660-e669 PMID: 35907408 PMCID: PMC9444987 SCOPUS ID: 2-s2.0-85135889621 07/31/2022 77 Citations

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M) Transplant Cell Ther 2022 Jul;28(7):409.e1-409.e10 PMID: 35447374 PMCID: PMC9840526 SCOPUS ID: 2-s2.0-85130441260 04/22/2022 81 Citations

Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012. (Brunstein CG, O'Donnell PV, Logan B, Dawson P, Costa L, Cutler C, Craig M, Hogan W, Horowitz MM, Horwitz ME, Karanes C, Magenau JM, Malone A, McCarty J, McGuirk JP, Morris LE, Rezvani AR, Salit R, Vasu S, Eapen M, Fuchs EJ, Blood and Marrow Transplant Clinical Trials Network) Transplant Cell Ther 2022 Jul;28(7):406.e1-406.e6 PMID: 35390529 PMCID: PMC9253061 SCOPUS ID: 2-s2.0-85130454080 04/08/2022 7 Citations

Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. (St Martin A, Hebert KM, Serret-Larmande A, Jouhet V, Hughes E, Stedman J, DeSain T, Pillion D, Lyons JC, Steinert P, Avillach P, Eapen M) Transplant Cell Ther 2022 Jun;28(6):325.e1-325.e7 PMID: 35302009 PMCID: PMC9198002 SCOPUS ID: 2-s2.0-85128216222 03/19/2022 14 Citations

Since everyone has a donor, why are some eligible patients still not transplanted? (Eapen M) Best Pract Res Clin Haematol 2021 Dec;34(4):101321 PMID: 34865693 SCOPUS ID: 2-s2.0-85117861200 12/07/2021 6 Citations

Since everyone has a donor, why are some eligible patients still not transplanted? (Eapen M) Best Practice and Research Clinical Haematology December 2021;34(4) SCOPUS ID: 2-s2.0-85117861200 12/01/2021 6 Citations

Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. (O'Donnell PV, Brunstein CG, Fuchs EJ, Zhang MJ, Allbee-Johnson M, Antin JH, Leifer ES, Elmariah H, Grunwald MR, Hashmi H, Horowitz MM, Magenau JM, Majhail N, Milano F, Morris LE, Rezvani AR, McGuirk JP, Jones RJ, Eapen M) Transplant Cell Ther 2022 Feb;28(2):109.e1-109.e8 PMID: 34775146 PMCID: PMC8882346 SCOPUS ID: 2-s2.0-85121144074 11/15/2021 24 Citations

Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia. (Cancio M, Hebert K, Kim S, Aljurf M, Olson T, Anderson E, Burroughs L, Vatsayan A, Myers K, Hashem H, Hanna R, Horn B, Prestidge T, Boelens JJ, Boulad F, Eapen M) Transplant Cell Ther 2022 Feb;28(2):101.e1-101.e6 PMID: 34670170 PMCID: PMC8816844 SCOPUS ID: 2-s2.0-85121465968 10/21/2021 16 Citations

Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. (Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M) Transplant Cell Ther 2021 Dec;27(12):993.e1-993.e8 PMID: 34507002 PMCID: PMC8671234 SCOPUS ID: 2-s2.0-85120751167 09/11/2021 9 Citations

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM) Transplant Cell Ther 2021 Nov;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021 19 Citations

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning. (Wagner JE, Ballen KK, Zhang MJ, Allbee-Johnson M, Karanes C, Milano F, Verneris MR, Eapen M, Brunstein CG) Blood Adv 2021 Oct 26;5(20):4064-4072 PMID: 34461630 PMCID: PMC8945645 SCOPUS ID: 2-s2.0-85118551689 08/31/2021 33 Citations

Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders. (Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino VM, Baker KS, Chellapandian D, Dávila Saldaña B, Duncan CN, Eckrich MJ, Georges GE, Olson TS, Pulsipher MA, Shenoy S, Stenger E, Lugt MV, Yu LC, Gennery AR, Eapen M) J Allergy Clin Immunol 2022 Mar;149(3):1097-1104.e2 PMID: 34375618 PMCID: PMC8821728 SCOPUS ID: 2-s2.0-85114615522 08/11/2021 39 Citations

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. (Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M) Blood 2021 Jul 22;138(3):273-282 PMID: 34292325 PMCID: PMC8310426 SCOPUS ID: 2-s2.0-85111698532 07/23/2021 156 Citations

Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients. (Brunstein CG, DeFor TE, Fuchs EJ, Karanes C, McGuirk JP, Rezvani AR, Eapen M, O'Donnell PV, Weisdorf DJ, Blood and Marrow Transplant Clinical Trials Network) Transplant Cell Ther 2021 Oct;27(10):879.e1-879.e3 PMID: 34273598 PMCID: PMC8858593 SCOPUS ID: 2-s2.0-85117537593 07/18/2021

Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. (Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D) Leukemia 2021 Jul;35(7):2140 PMID: 34088982 PMCID: PMC8329698 SCOPUS ID: 2-s2.0-85107597501 06/06/2021 1 Citation

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. (Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D) Leukemia 2021 Jul;35(7):2076-2085 PMID: 33785862 PMCID: PMC8257494 SCOPUS ID: 2-s2.0-85103388621 04/01/2021 40 Citations

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors. (Grunwald MR, Zhang MJ, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf DJ, Eapen M) Blood Adv 2021 Feb 23;5(4):975-983 PMID: 33576783 PMCID: PMC7903230 SCOPUS ID: 2-s2.0-85102602689 02/13/2021 51 Citations

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. (Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG) Blood 2021 Jan 21;137(3):420-428 PMID: 33475736 PMCID: PMC7819761 SCOPUS ID: 2-s2.0-85092507677 01/22/2021 201 Citations

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation. (Qayed M, Ahn KW, Kitko CL, Johnson MH, Shah NN, Dvorak C, Mellgren K, Friend BD, Verneris MR, Leung W, Toporski J, Levine J, Chewning J, Wayne A, Kapoor U, Triplett B, Schultz KR, Yanik GA, Eapen M) Blood 2021 Feb 18;137(7):983-993 PMID: 33206937 PMCID: PMC7918183 SCOPUS ID: 2-s2.0-85101021587 11/19/2020 34 Citations

Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome. (Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, Piątosa B, Pietrucha B, Kałwak K, Ussowicz M, Pieczonka A, Drabko K, Lejman M, Koltan S, Gozdzik J, Styczynski J, Fedorova A, Miakova N, Deripapa E, Kostyuchenko L, Krenova Z, Hlavackova E, Gennery AR, Sykora KW, Ghosh S, Albert MH, Balashov D, Eapen M, Svec P, Seidel MG, Kilic SS, Tomaszewska A, Wiesik-Szewczyk E, Kreins A, Greil J, Buechner J, Lund B, Gregorek H, Chrzanowska K, Mlynarski W) Clin Cancer Res 2021 Jan 15;27(2):575-584 PMID: 33082212 SCOPUS ID: 2-s2.0-85100264437 10/22/2020 37 Citations

The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study. (George G, Martin AS, Chhabra S, Eapen M) Biol Blood Marrow Transplant 2020 Dec;26(12):2359-2364 PMID: 32818554 PMCID: PMC7686090 SCOPUS ID: 2-s2.0-85091241149 08/21/2020 7 Citations

Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant. (Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M) Biol Blood Marrow Transplant 2020 Oct;26(10):1930-1936 PMID: 32649981 PMCID: PMC7530013 SCOPUS ID: 2-s2.0-85089075393 07/11/2020 12 Citations

Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children. (Dandoy CE, Davies SM, Woo Ahn K, He Y, Kolb AE, Levine J, Bo-Subait S, Abdel-Azim H, Bhatt N, Chewning J, Gadalla S, Gloude N, Hayashi R, Lalefar NR, Law J, MacMillan M, O'Brien T, Prestidge T, Sharma A, Shaw P, Winestone L, Eapen M) Haematologica 2021 Jul 01;106(7):1839-1845 PMID: 32554562 PMCID: PMC8252927 SCOPUS ID: 2-s2.0-85086742043 06/20/2020 23 Citations

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease. (Brazauskas R, Scigliuolo GM, Wang HL, Cappelli B, Ruggeri A, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Panepinto JA, Rondelli D, Shenoy S, Walters MC, Wagner JE, Tisdale JF, Gluckman E, Eapen M) Blood 2020 Jul 30;136(5):623-626 PMID: 32518950 PMCID: PMC7393258 SCOPUS ID: 2-s2.0-85089126120 06/11/2020 40 Citations

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020 492 Citations

Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome. (Myers K, Hebert K, Antin J, Boulad F, Burroughs L, Hofmann I, Kamble R, MacMillan ML, Eapen M) Biol Blood Marrow Transplant 2020 Aug;26(8):1446-1451 PMID: 32428734 PMCID: PMC7371524 SCOPUS ID: 2-s2.0-85086565275 05/20/2020 44 Citations

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020 47 Citations

Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. (Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M) J Clin Oncol 2020 May 10;38(14):1518-1526 PMID: 32031876 PMCID: PMC7213591 SCOPUS ID: 2-s2.0-85084380128 02/08/2020 41 Citations

A resurgence of cord blood transplantation? (Eapen M) Lancet Haematol 2020 Feb;7(2):e89-e90 PMID: 31704263 SCOPUS ID: 2-s2.0-85078869834 11/11/2019 2 Citations

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. (Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M) Blood Adv 2019 Oct 22;3(20):3123-3131 PMID: 31648332 PMCID: PMC6849938 SCOPUS ID: 2-s2.0-85075150491 10/28/2019 57 Citations

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. (Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M) Blood Adv 2019 Oct 08;3(19):2836-2844 PMID: 31582392 PMCID: PMC6784523 SCOPUS ID: 2-s2.0-85073446898 10/05/2019 45 Citations

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. (Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Bolaños-Meade J, Panepinto JA, Rondelli D, Shenoy S, Williamson J, Woolford TL, Gluckman E, Wagner JE, Tisdale JF) Lancet Haematol 2019 Nov;6(11):e585-e596 PMID: 31495699 PMCID: PMC6813907 SCOPUS ID: 2-s2.0-85073535787 09/10/2019 184 Citations

Related and unrelated donor transplantation for β-thalassemia major: results of an international survey. (Li C, Mathews V, Kim S, George B, Hebert K, Jiang H, Li C, Zhu Y, Keesler DA, Boelens JJ, Dvorak CC, Agarwal R, Auletta JJ, Goyal RK, Hanna R, Kasow K, Shenoy S, Smith AR, Walters MC, Eapen M) Blood Adv 2019 Sep 10;3(17):2562-2570 PMID: 31471325 PMCID: PMC6737407 SCOPUS ID: 2-s2.0-85072156526 09/01/2019 86 Citations

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. (Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, Confer DL, Eapen M, Fernandez-Vina M, Hartzman R, Maiers M, Marino SR, Mueller C, Perales MA, Rajalingam R, Pidala J) Blood 2019 Sep 19;134(12):924-934 PMID: 31292117 PMCID: PMC6753623 SCOPUS ID: 2-s2.0-85070717555 07/12/2019 300 Citations

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor? (Perales MA, Tomlinson B, Zhang MJ, St Martin A, Beitinjaneh A, Gibson J, Hogan W, Kekre N, Lazarus H, Marks D, McGuirk J, Romee R, Solh M, Wagner JE, Weisdorf DJ, de Lima M, Eapen M) Haematologica 2020;105(2):407-413 PMID: 31101756 PMCID: PMC7012481 SCOPUS ID: 2-s2.0-85076246697 05/19/2019 32 Citations

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL. (Dreger P, Sureda A, Ahn KW, Eapen M, Litovich C, Finel H, Boumendil A, Gopal A, Herrera AF, Schmid C, Diez-Martin JL, Fuchs E, Bolaños-Meade J, Gooptu M, Al Malki MM, Castagna L, Ciurea SO, Dominietto A, Blaise D, Ciceri F, Tischer J, Corradini P, Montoto S, Robinson S, Gülbas Z, Hamadani M) Blood Adv 2019 Feb 12;3(3):360-369 PMID: 30723110 PMCID: PMC6373757 SCOPUS ID: 2-s2.0-85061139017 02/07/2019 109 Citations

In-vivo T-cell depletion: burden of morbidity versus survival. (Eapen M) Lancet Haematol 2019 Feb;6(2):e63-e64 PMID: 30709434 SCOPUS ID: 2-s2.0-85060516116 02/03/2019

Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601. (King AA, McKinstry RC, Wu J, Eapen M, Abel R, Varughese T, Kamani N, Shenoy S) Biol Blood Marrow Transplant 2019 May;25(5):e174-e178 PMID: 30639825 PMCID: PMC6511327 SCOPUS ID: 2-s2.0-85061190072 01/15/2019 28 Citations

Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. (Lund TC, Ahn KW, Tecca HR, Hilgers MV, Abdel-Azim H, Abraham A, Diaz MA, Badawy SM, Broglie L, Brown V, Dvorak CC, Gonzalez-Vicent M, Hashem H, Hayashi RJ, Jacobsohn DA, Kent MW, Li CK, Margossian SP, Martin PL, Mehta P, Myers K, Olsson R, Page K, Pulsipher MA, Shaw PJ, Smith AR, Triplett BM, Verneris MR, Eapen M) Biol Blood Marrow Transplant 2019 Feb;25(2):301-306 PMID: 30244103 PMCID: PMC6339844 SCOPUS ID: 2-s2.0-85055126522 09/24/2018 47 Citations

Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia. (Rice C, Eikema DJ, Marsh JCW, Knol C, Hebert K, Putter H, Peterson E, Deeg HJ, Halkes S, Pidala J, Anderlini P, Tischer J, Kroger N, McDonald A, Antin JH, Schaap NP, Hallek M, Einsele H, Mathews V, Kapoor N, Boelens JJ, Mufti GJ, Potter V, Pefault de la Tour R, Eapen M, Dufour C) Biol Blood Marrow Transplant 2019 Mar;25(3):488-495 PMID: 30194027 PMCID: PMC6401340 SCOPUS ID: 2-s2.0-85054749211 09/09/2018 37 Citations

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. (Marsh RA, Hebert KM, Keesler D, Boelens JJ, Dvorak CC, Eckrich MJ, Kapoor N, Parikh S, Eapen M) J Allergy Clin Immunol 2018 Dec;142(6):2004-2007 PMID: 30170121 PMCID: PMC6289686 SCOPUS ID: 2-s2.0-85053864670 09/01/2018 19 Citations

Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia. (Keesler DA, St Martin A, Bonfim C, Seber A, Zhang MJ, Eapen M) Biol Blood Marrow Transplant 2018 Dec;24(12):2487-2492 PMID: 30142417 PMCID: PMC6286246 SCOPUS ID: 2-s2.0-85053734750 08/25/2018 18 Citations

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity. (Eapen M, Brazauskas R, Hemmer M, Perez WS, Steinert P, Horowitz MM, Deeg HJ) Blood Adv 2018 Aug 28;2(16):2095-2103 PMID: 30135184 PMCID: PMC6113615 SCOPUS ID: 2-s2.0-85056694237 08/24/2018 77 Citations

Is a matched sibling the ideal donor for hematopoietic cell transplant? (Eapen M) Haematologica 2018 Aug;103(8):1251-1252 PMID: 30065017 PMCID: PMC6068016 SCOPUS ID: 2-s2.0-85051105844 08/02/2018

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. (Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA) Blood 2018 Sep 27;132(13):1438-1451 PMID: 29997222 PMCID: PMC6161764 SCOPUS ID: 2-s2.0-85053908983 07/13/2018 98 Citations

Surviving childhood cancer: a sobering story. (Eapen M) Blood 2018 Jun 14;131(24):2603-2604 PMID: 29903869 SCOPUS ID: 2-s2.0-85048706873 06/16/2018

Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? (Robinson TM, Fuchs EJ, Zhang MJ, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis JH, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research) Blood Adv 2018 Jun 12;2(11):1180-1186 PMID: 29794073 PMCID: PMC5998932 SCOPUS ID: 2-s2.0-85051130706 05/26/2018 42 Citations

Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. (Stiff PJ, Montesinos P, Peled T, Landau E, Goudsmid NR, Mandel J, Hasson N, Olesinski E, Glukhman E, Snyder DA, Cohen EG, Kidron OS, Bracha D, Harati D, Ben-Abu K, Freind E, Freedman LS, Cohen YC, Olmer L, Barishev R, Rocha V, Gluckman E, Horowitz MM, Eapen M, Nagler A, Sanz G) Biol Blood Marrow Transplant 2018 Jul;24(7):1463-1470 PMID: 29477778 PMCID: PMC6045964 SCOPUS ID: 2-s2.0-85044995501 02/27/2018 46 Citations

Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. (McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M) Blood Adv 2018 Feb 13;2(3):299-307 PMID: 29440002 PMCID: PMC5812334 SCOPUS ID: 2-s2.0-85050645336 02/15/2018 90 Citations

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. (Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M) Haematologica 2018 Apr;103(4):717-727 PMID: 29351985 PMCID: PMC5865423 SCOPUS ID: 2-s2.0-85044420638 01/21/2018 47 Citations

Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant? (Eapen M) Best Pract Res Clin Haematol 2017 Dec;30(4):317-319 PMID: 29156202 SCOPUS ID: 2-s2.0-85029852901 11/21/2017 3 Citations

Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease. (Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, Guilcher G, Kamani N, Walters MC, Boelens JJ, Tisdale J, Shenoy S, National Institutes of Health, Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2017 Dec;23(12):2178-2183 PMID: 28882446 PMCID: PMC5782809 SCOPUS ID: 2-s2.0-85031102573 09/09/2017 96 Citations

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. (Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE) Biol Blood Marrow Transplant 2017 Oct;23(10):1714-1721 PMID: 28684372 PMCID: PMC5605440 SCOPUS ID: 2-s2.0-85026649100 07/08/2017 22 Citations

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes (Mary Eapen, Joanne Kurtzberg, Mei-Jie Zhang, Gareth Hattersely, Mingwei Fei, Adam Mendizabal, Ka Wah Chan, Satiro De Oliveira, Kirk R Schultz, Donna Wall, Mary M Horowitz, John E Wagner) Biol Blood Marrow Transplant Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE. Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. Biol Blood Marrow Transplant. 2017 Oct;23(10):1714-1721. doi: 10.1016/j.bbmt.2017.06.023. Epub 2017 Jul 3. PMID: 28684372; PMCID: PMC5605440. 07/03/2017

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. (Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M) J Clin Oncol 2017 Sep 10;35(26):3002-3009 PMID: 28644773 PMCID: PMC5590802 SCOPUS ID: 2-s2.0-85029169856 06/24/2017 286 Citations

Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A) Lancet Haematol 2017 Jul;4(7):e325-e333 PMID: 28623181 PMCID: PMC5699478 SCOPUS ID: 2-s2.0-85020732533 06/18/2017 83 Citations

HCT for SCID: one size does not fit all. (Eapen M) Blood 2017 May 25;129(21):2826-2827 PMID: 28546225 SCOPUS ID: 2-s2.0-85019718133 05/27/2017

Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation. (Bitan M, Ahn KW, Millard HR, Pulsipher MA, Abdel-Azim H, Auletta JJ, Brown V, Chan KW, Diaz MA, Dietz A, Vincent MG, Guilcher G, Hale GA, Hayashi RJ, Keating A, Mehta P, Myers K, Page K, Prestidge T, Shah NN, Smith AR, Woolfrey A, Thiel E, Davies SM, Eapen M) Biol Blood Marrow Transplant 2017 Sep;23(9):1523-1530 PMID: 28527984 PMCID: PMC5683075 SCOPUS ID: 2-s2.0-85020896551 05/22/2017 15 Citations

Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. (Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora KW, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiencies, Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE), Center for International Blood and Marrow Transplant Research, Primary Immunodeficiency Treatment Consortium) J Allergy Clin Immunol 2018 Jan;141(1):322-328.e10 PMID: 28392333 PMCID: PMC5632132 SCOPUS ID: 2-s2.0-85018987484 04/11/2017 99 Citations

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. (Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH) Haematologica 2017 Jul;102(7):1291-1298 PMID: 28341733 PMCID: PMC5566045 SCOPUS ID: 2-s2.0-85021431019 03/28/2017 50 Citations

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. (Brunstein C, Zhang MJ, Barker J, St Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M) Haematologica 2017 May;102(5):941-947 PMID: 28126967 PMCID: PMC5477613 SCOPUS ID: 2-s2.0-85018992448 01/28/2017 15 Citations

Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis. (Ustun C, Giannotti F, Zhang MJ, Wang HL, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier BM, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A) Leukemia 2017 Jun;31(6):1408-1414 PMID: 28119528 PMCID: PMC5462854 SCOPUS ID: 2-s2.0-85012303056 01/26/2017 21 Citations

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. (Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M) Cancer 2017 Jun 01;123(11):2025-2034 PMID: 28117884 PMCID: PMC5445001 SCOPUS ID: 2-s2.0-85019595123 01/25/2017 58 Citations

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. (Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M, Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research) Blood 2017 Mar 16;129(11):1548-1556 PMID: 27965196 PMCID: PMC5356458 SCOPUS ID: 2-s2.0-85015934863 12/15/2016 431 Citations

Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia. (Bonfim C, Ribeiro L, Nichele S, Loth G, Bitencourt M, Koliski A, Kuwahara C, Fabro AL, Pereira NF, Pilonetto D, Thakar M, Kiem HP, Page K, Fuchs EJ, Eapen M, Pasquini R) Biol Blood Marrow Transplant 2017 Feb;23(2):310-317 PMID: 27832981 SCOPUS ID: 2-s2.0-85007414127 11/12/2016 59 Citations

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 SCOPUS ID: 2-s2.0-85015019083 09/15/2016 191 Citations

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 Dec;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 SCOPUS ID: 2-s2.0-84982085195 08/16/2016 45 Citations

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. (Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S) Bone Marrow Transplant 2017 Jan;52(1):59-65 PMID: 27427921 PMCID: PMC5215562 SCOPUS ID: 2-s2.0-84978696407 07/19/2016 20 Citations

Donor and recipient sex in allogeneic stem cell transplantation: what really matters. (Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, Perales MA, Armand P, Eapen M) Haematologica 2016 Oct;101(10):1260-1266 PMID: 27354023 PMCID: PMC5046656 SCOPUS ID: 2-s2.0-84989332191 06/30/2016 82 Citations

Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey. (Rafii H, Ruggeri A, Volt F, Brunstein CG, Carreras J, Eapen M, Gluckman E, Weisdorf DJ) Biol Blood Marrow Transplant 2016 Sep;22(9):1717-1720 PMID: 27220265 SCOPUS ID: 2-s2.0-84991233899 05/26/2016 9 Citations

Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. (Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M, Eurocord, Cord Blood Committee Cellular Therapy Immunobiology Working Party of the European Group for Blood and Marrow Transplantation, Netcord, and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2016 Jul;22(7):1284-1289 PMID: 27090957 PMCID: PMC4915071 SCOPUS ID: 2-s2.0-84975275493 04/20/2016 29 Citations

Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia. (Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R) Biol Blood Marrow Transplant 2016 Jul;22(7):1257-1263 PMID: 26976241 SCOPUS ID: 2-s2.0-84964339368 03/16/2016 65 Citations

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. (Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M) Lancet Haematol 2015 Sep;2(9):e367-75 PMID: 26685770 PMCID: PMC4861234 SCOPUS ID: 2-s2.0-84954025938 12/22/2015 78 Citations

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7 PMID: 26527675 PMCID: PMC4713163 SCOPUS ID: 2-s2.0-84955452671 11/04/2015 327 Citations

Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation. (Pagliuca S, Gérard L, Kulasekararaj A, Eapen M, Boutboul D, Martin H, Salvino MA, Knol-Bout C, Dufour C, Peffault de Latour R, Marsh J) Bone Marrow Transplant 2016 Feb;51(2):313-5 PMID: 26479981 SCOPUS ID: 2-s2.0-84956924156 10/20/2015 8 Citations

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. (Ponce DM, Eapen M, Sparapani R, O'Brien TA, Chan KW, Chen J, Craddock J, Schultz KR, Wagner JE, Perales MA, Barker JN) Biol Blood Marrow Transplant 2015 Dec;21(12):2173-2179 PMID: 26327630 PMCID: PMC4639413 SCOPUS ID: 2-s2.0-84947422775 09/04/2015 19 Citations

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. (Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, Pingali SR, Porter DL, Riches MR, Ringdén OT, Rocha V, Vij R, Weisdorf DJ, Champlin RE, Horowitz MM, Fuchs EJ, Eapen M) Blood 2015 Aug 20;126(8):1033-40 PMID: 26130705 PMCID: PMC4543223 SCOPUS ID: 2-s2.0-84940039514 07/02/2015 598 Citations

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. (Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, Radhi M, Shah AJ, Schultz KR, Wirk B, Wagner JE, Deeg HJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1790-5 PMID: 26116087 PMCID: PMC4568139 SCOPUS ID: 2-s2.0-84941315963 06/28/2015 6 Citations

Who is the best alternative allotransplant donor? (Gale RP, Eapen M) Bone Marrow Transplant 2015 Jun;50 Suppl 2(0 2):S40-2 PMID: 26039206 PMCID: PMC4520408 SCOPUS ID: 2-s2.0-84930420699 06/04/2015 12 Citations

Hematopoietic stem cell transplantation for infantile osteopetrosis. (Orchard PJ, Fasth AL, Le Rademacher J, He W, Boelens JJ, Horwitz EM, Al-Seraihy A, Ayas M, Bonfim CM, Boulad F, Lund T, Buchbinder DK, Kapoor N, O'Brien TA, Perez MA, Veys PA, Eapen M) Blood 2015 Jul 09;126(2):270-6 PMID: 26012570 PMCID: PMC4497967 SCOPUS ID: 2-s2.0-84937866555 05/28/2015 100 Citations

Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. (Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Pérez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, Lund TC, Leung WH, Davies SM) Biol Blood Marrow Transplant 2015 Jul;21(7):1273-7 PMID: 25865650 PMCID: PMC4465998 SCOPUS ID: 2-s2.0-84930582139 04/14/2015 27 Citations

Hematopoietic cell transplantation for acute leukemia: selecting donors. (Eapen M) Haematologica 2015 Apr;100(4):414-5 PMID: 25828086 PMCID: PMC4380712 SCOPUS ID: 2-s2.0-84926304536 04/02/2015 2 Citations

Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. (Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, Dalissier A, Davis JH, Eames GM, Egeler RM, Filipovich AH, Fischer A, Jürgens H, Krance R, Lanino E, Leung WH, Matthes S, Michel G, Orchard PJ, Pieczonka A, Ringdén O, Schlegel PG, Sirvent A, Vettenranta K, Eapen M) Br J Haematol 2015 Jun;169(5):711-8 PMID: 25817915 PMCID: PMC4433436 SCOPUS ID: 2-s2.0-84929258260 03/31/2015 69 Citations

One-unit versus two-unit cord-blood transplantation. (Wagner JE Jr, Eapen M, Kurtzberg J) N Engl J Med 2015 Jan 15;372(3):288 PMID: 25587953 SCOPUS ID: 2-s2.0-84920984085 01/15/2015 3 Citations

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M) Biol Blood Marrow Transplant 2015 Apr;21(4):688-95 PMID: 25543094 PMCID: PMC4359657 SCOPUS ID: 2-s2.0-84924284376 12/30/2014 15 Citations

Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 SCOPUS ID: 2-s2.0-84921903392 12/24/2014 48 Citations

Unrelated donor transplantation: peripheral blood or bone marrow--does it matter? (Eapen M) Best Pract Res Clin Haematol 2014;27(3-4):278-82 PMID: 25455278 SCOPUS ID: 2-s2.0-84923858062 12/03/2014 6 Citations

One-unit versus two-unit cord-blood transplantation for hematologic cancers. (Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2014 Oct 30;371(18):1685-94 PMID: 25354103 PMCID: PMC4257059 SCOPUS ID: 2-s2.0-84908406651 10/30/2014 252 Citations

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. (Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE) Biol Blood Marrow Transplant 2015 Jan;21(1):55-9 PMID: 25255165 PMCID: PMC4272909 SCOPUS ID: 2-s2.0-84927166028 09/26/2014 31 Citations

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. (Kim SY, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ) Haematologica 2014 Dec;99(12):1868-75 PMID: 25107891 PMCID: PMC4258748 SCOPUS ID: 2-s2.0-84919384670 08/12/2014 25 Citations

HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. (Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M) N Engl J Med 2014 Jul 24;371(4):339-48 PMID: 25054717 PMCID: PMC5965695 SCOPUS ID: 2-s2.0-84904566576 07/24/2014 1010 Citations

Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. (Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, Katsanis E, Lewis VA, Sahdev I, Orchard PJ) Biol Blood Marrow Transplant 2014 Nov;20(11):1847-51 PMID: 25016194 PMCID: PMC4194244 SCOPUS ID: 2-s2.0-84908075401 07/13/2014 38 Citations

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. (Ruggeri A, Labopin M, Sormani MP, Sanz G, Sanz J, Volt F, Michel G, Locatelli F, Diaz De Heredia C, O'Brien T, Arcese W, Iori AP, Querol S, Kogler G, Lecchi L, Pouthier F, Garnier F, Navarrete C, Baudoux E, Fernandes J, Kenzey C, Eapen M, Gluckman E, Rocha V, Saccardi R, Eurocord, Cord Blood Committee EBMT, Netcord) Haematologica 2014 Sep;99(9):1509-15 PMID: 24972767 PMCID: PMC4562541 SCOPUS ID: 2-s2.0-84907340664 06/29/2014 53 Citations

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. (Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M) Biol Blood Marrow Transplant 2014 Sep;20(9):1418-25 PMID: 24892261 PMCID: PMC4127369 SCOPUS ID: 2-s2.0-84905586102 06/04/2014 46 Citations

Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. (Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A, Fuchs EJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1485-92 PMID: 24862638 PMCID: PMC4163123 SCOPUS ID: 2-s2.0-84912522258 05/28/2014 44 Citations

Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. (Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD) J Comp Eff Res 2014 Mar;3(2):135-44 PMID: 24645687 PMCID: PMC4036637 SCOPUS ID: 2-s2.0-84897837351 03/22/2014 16 Citations

Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. (Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E) Biol Blood Marrow Transplant 2014 Jun;20(6):816-22 PMID: 24582782 PMCID: PMC4085692 SCOPUS ID: 2-s2.0-84899907330 03/04/2014 78 Citations

Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7 PMID: 24525277 PMCID: PMC4071962 SCOPUS ID: 2-s2.0-84897957526 02/15/2014 22 Citations

Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Pediatr Blood Cancer 2014 Jun;61(6):1126-8 PMID: 24391118 PMCID: PMC4080799 SCOPUS ID: 2-s2.0-84898801407 01/07/2014 40 Citations

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR) Biol Blood Marrow Transplant 2014 Feb;20(2):202-8 PMID: 24184335 PMCID: PMC3924751 SCOPUS ID: 2-s2.0-84893149821 11/05/2013 35 Citations

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V, Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation) Blood 2014 Jan 02;123(1):133-40 PMID: 24141369 PMCID: PMC3879902 SCOPUS ID: 2-s2.0-84891778061 10/22/2013 242 Citations

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. (Eckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M) Am J Hematol 2014 Feb;89(2):125-9 PMID: 24122901 PMCID: PMC4109804 SCOPUS ID: 2-s2.0-84893935238 10/15/2013 31 Citations

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. (Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales MA, Pidala J, Savani B, Rocha V, Eapen M) Haematologica 2014 Feb;99(2):322-8 PMID: 24056817 PMCID: PMC3912963 SCOPUS ID: 2-s2.0-84896710891 09/24/2013 75 Citations

Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. (Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG) Pediatr Blood Cancer 2014 Feb;61(2):269-75 PMID: 23955900 PMCID: PMC3919967 SCOPUS ID: 2-s2.0-84890874028 08/21/2013 34 Citations

Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. (Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML, Zecca M, Kurtzberg J, Bonfim C, Vora A, Díaz de Heredia C, Teague L, Stein J, O'Brien TA, Bittencourt H, Madureira A, Strahm B, Peters C, Niemeyer C, Gluckman E, Rocha V) Blood 2013 Sep 19;122(12):2135-41 PMID: 23926304 PMCID: PMC3836039 SCOPUS ID: 2-s2.0-84887600939 08/09/2013 90 Citations

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. (Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA) Biol Blood Marrow Transplant 2013 Aug;19(8):1238-43 PMID: 23751955 PMCID: PMC3736557 SCOPUS ID: 2-s2.0-84880448795 06/12/2013 116 Citations

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. (Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O'Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V, Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University Blood and Marrow Transplantation Program, Centre for International Blood and Marrow Research) Blood 2013 May 09;121(19):3981-7 PMID: 23493783 PMCID: PMC3836041 SCOPUS ID: 2-s2.0-84880314796 03/16/2013 191 Citations

Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Biol Blood Marrow Transplant 2013 Jun;19(6):893-7 PMID: 23467128 PMCID: PMC3707801 SCOPUS ID: 2-s2.0-84877892412 03/08/2013 48 Citations

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? (Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, Eapen M, Champlin RE) Blood 2013 Mar 28;121(13):2567-73 PMID: 23361908 PMCID: PMC3612864 SCOPUS ID: 2-s2.0-84878406500 01/31/2013 121 Citations

Cord-blood engraftment with ex vivo mesenchymal-cell coculture. (de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ) N Engl J Med 2012 Dec 13;367(24):2305-15 PMID: 23234514 PMCID: PMC3805360 SCOPUS ID: 2-s2.0-84871071832 12/14/2012 431 Citations

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. (Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ) Blood 2013 Jan 31;121(5):752-8 PMID: 23223509 PMCID: PMC3563363 SCOPUS ID: 2-s2.0-84873542634 12/12/2012 169 Citations

HCT for nonmalignant disorders. (Tisdale JF, Eapen M, Saccardi R) Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S6-9 PMID: 23104188 SCOPUS ID: 2-s2.0-84871898415 10/30/2012 6 Citations

Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. (Tracey J, Zhang MJ, Thiel E, Sobocinski KA, Eapen M) Biol Blood Marrow Transplant 2013 Feb;19(2):255-9 PMID: 23041605 PMCID: PMC3553255 SCOPUS ID: 2-s2.0-84872606979 10/09/2012 30 Citations

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. (Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A) Blood 2012 Oct 04;120(14):2918-24 PMID: 22829628 PMCID: PMC3466972 SCOPUS ID: 2-s2.0-84867297995 07/26/2012 106 Citations

Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M, Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2012 Dec;18(12):1890-6 PMID: 22814031 PMCID: PMC3826155 SCOPUS ID: 2-s2.0-84869090988 07/21/2012 70 Citations

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 SCOPUS ID: 2-s2.0-84867505772 07/07/2012 134 Citations

A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 SCOPUS ID: 2-s2.0-84864144424 05/19/2012 135 Citations

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. (Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis VA, Steward C, Wagner JE, Carpenter PA, Eapen M) Blood 2012 Jun 21;119(25):6155-61 PMID: 22573402 PMCID: PMC3383023 SCOPUS ID: 2-s2.0-84862745582 05/11/2012 42 Citations

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. (Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P) Biol Blood Marrow Transplant 2012 Jul;18(7):1007-11 PMID: 22546497 PMCID: PMC3677744 SCOPUS ID: 2-s2.0-84862131215 05/02/2012 51 Citations

Allogeneic transplantation for aplastic anemia. (Eapen M) Hematology 2012 Apr;17 Suppl 1:S15-7 PMID: 22507769 SCOPUS ID: 2-s2.0-84859760352 04/25/2012 5 Citations

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. (Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ, Weisdorf DJ, Woolfrey A, Wagner JE) Blood 2012 Jun 07;119(23):5591-8 PMID: 22496153 PMCID: PMC3369691 SCOPUS ID: 2-s2.0-84862513845 04/13/2012 112 Citations

Peripheral blood or marrow: is one better than the other? (Eapen M) Biol Blood Marrow Transplant 2012 Jun;18(6):819 PMID: 22449609 SCOPUS ID: 2-s2.0-84860813842 03/28/2012

Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. (Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA, Gross TG, Horwitz M, Horwitz E, Kapoor N, Kurtzberg J, Majhail N, Ringden O, Szabolcs P, Veys P, Baker KS) Biol Blood Marrow Transplant 2012 Sep;18(9):1438-45 PMID: 22430083 PMCID: PMC3390445 SCOPUS ID: 2-s2.0-84865199175 03/21/2012 46 Citations

Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID: 22406037 PMCID: PMC3890239 SCOPUS ID: 2-s2.0-84864005064 03/13/2012 54 Citations

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. (Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, Bajwa RP, George B, Gupta V, Pasquini R, Schrezenmeier H, Passweg JR, Schultz KR, Eapen M) Biol Blood Marrow Transplant 2012 Sep;18(9):1401-6 PMID: 22387349 PMCID: PMC3406237 SCOPUS ID: 2-s2.0-84865157149 03/06/2012 6 Citations

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID: 22343376 PMCID: PMC3618440 SCOPUS ID: 2-s2.0-84864005843 02/22/2012 181 Citations

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. (Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V, Eurocord-European Group for Blood and Marrow Transplantation, Netcord, Center for International Blood and Marrow Transplant Research) Lancet Oncol 2011 Dec;12(13):1214-21 PMID: 21982422 PMCID: PMC3245836 SCOPUS ID: 2-s2.0-82555165881 10/11/2011 185 Citations

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. (Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M) Biol Blood Marrow Transplant 2011 Dec;17(12):1869-73 PMID: 21771571 PMCID: PMC3217167 SCOPUS ID: 2-s2.0-81255172445 07/21/2011 33 Citations

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission. (Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA) Biol Blood Marrow Transplant 2011 Dec;17(12):1833-40 PMID: 21683798 PMCID: PMC3372321 SCOPUS ID: 2-s2.0-81255161748 06/21/2011 15 Citations

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. (Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ) Blood 2011 Sep 01;118(9):2618-21 PMID: 21677312 PMCID: PMC3167362 SCOPUS ID: 2-s2.0-80052406910 06/17/2011 143 Citations

Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. (Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH) Biol Blood Marrow Transplant 2011 Dec;17(12):1783-9 PMID: 21658461 PMCID: PMC3370408 SCOPUS ID: 2-s2.0-81255185230 06/11/2011 30 Citations

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. (Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV, Blood and Marrow Transplant Clinical Trials Network) Blood 2011 Jul 14;118(2):282-8 PMID: 21527516 PMCID: PMC3138683 SCOPUS ID: 2-s2.0-79960465258 04/30/2011 513 Citations

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 PMID: 21464372 PMCID: PMC3128486 SCOPUS ID: 2-s2.0-79959496711 04/06/2011 321 Citations

Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. (Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V, Eurocord Registry, Center for International Blood and Marrow Transplant Research, New York Blood Center) Biol Blood Marrow Transplant 2011 Sep;17(9):1375-82 PMID: 21277376 PMCID: PMC3395002 SCOPUS ID: 2-s2.0-80051666676 02/01/2011 186 Citations

Alternative donor transplantation for aplastic anemia. (Eapen M, Horowitz MM) Hematology Am Soc Hematol Educ Program 2010;2010:43-6 PMID: 21239769 SCOPUS ID: 2-s2.0-79955032731 01/18/2011 20 Citations

Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. (Madureira AB, Eapen M, Locatelli F, Teira P, Zhang MJ, Davies SM, Picardi A, Woolfrey A, Chan KW, Socié G, Vora A, Bertrand Y, Sales-Bonfim CM, Gluckman E, Niemeyer C, Rocha V, Eurocord-European Blood and Marrow Transplant Group, Center of International Blood and Marrow Transplant Registry, European Working Group on childhood MDS) Leukemia 2011 Mar;25(3):449-54 PMID: 21135856 PMCID: PMC3365546 SCOPUS ID: 2-s2.0-79952445223 12/08/2010 41 Citations

HLA-matched sibling bone marrow transplantation for β-thalassemia major. (Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC) Blood 2011 Feb 03;117(5):1745-50 PMID: 21119108 PMCID: PMC3056598 SCOPUS ID: 2-s2.0-79551639277 12/02/2010 117 Citations

Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. (Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH) Biol Blood Marrow Transplant 2011 Mar;17(3):291-9 PMID: 21034841 PMCID: PMC3053041 SCOPUS ID: 2-s2.0-79551684829 11/03/2010 34 Citations

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M) Biol Blood Marrow Transplant 2011 Jul;17(7):1018-24 PMID: 21034842 PMCID: PMC3114180 SCOPUS ID: 2-s2.0-79958756704 11/03/2010 60 Citations

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. (Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale RP, Hale GA, Ilhan O, Passweg JR, Ringdén O, Sabloff M, Schrezenmeier H, Socié G, Marsh JC) Haematologica 2010 Dec;95(12):2119-25 PMID: 20851870 PMCID: PMC2995571 SCOPUS ID: 2-s2.0-78649932299 09/21/2010 144 Citations

Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. (Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M) Biol Blood Marrow Transplant 2011 May;17(5):723-8 PMID: 20813197 PMCID: PMC3033968 SCOPUS ID: 2-s2.0-79954608298 09/04/2010 25 Citations

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. (Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center) Lancet Oncol 2010 Jul;11(7):653-60 PMID: 20558104 PMCID: PMC3163510 SCOPUS ID: 2-s2.0-77954031042 06/19/2010 535 Citations

Bone marrow or peripheral blood. (Eapen M) Biol Blood Marrow Transplant 2010 Jun;16(6):868-9 PMID: 20451848 SCOPUS ID: 2-s2.0-77952655531 05/11/2010

Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6 PMID: 20436518 PMCID: PMC3366187 SCOPUS ID: 2-s2.0-78651378621 05/04/2010 75 Citations

Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. (Verneris MR, Eapen M, Duerst R, Carpenter PA, Burke MJ, Afanasyev BV, Cowan MJ, He W, Krance R, Li CK, Tan PL, Wagner JE, Davies SM) Biol Blood Marrow Transplant 2010 Sep;16(9):1237-44 PMID: 20302960 PMCID: PMC2904410 SCOPUS ID: 2-s2.0-77955512467 03/23/2010 36 Citations

Transplant outcomes in acute leukemia. I. (Eapen M, Wagner JE) Semin Hematol 2010 Jan;47(1):46-50 PMID: 20109611 PMCID: PMC2814074 SCOPUS ID: 2-s2.0-72449180020 01/30/2010 14 Citations

Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease. (Tolar J, Eapen M, Orchard PJ, Blazar BR) Blood 2010 Jan 14;115(2):434-5 PMID: 20075175 SCOPUS ID: 2-s2.0-75649117464 01/16/2010 3 Citations

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. (Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ) Biol Blood Marrow Transplant 2010 Feb;16(2):253-62 PMID: 19822219 PMCID: PMC2952392 SCOPUS ID: 2-s2.0-75449094602 10/14/2009 27 Citations

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M) Biol Blood Marrow Transplant 2010 Feb;16(2):223-30 PMID: 19800015 PMCID: PMC2911354 SCOPUS ID: 2-s2.0-75149174146 10/06/2009 157 Citations

Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. (Horan JT, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J, Passweg JR, Walters MC, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):626-31 PMID: 19361755 PMCID: PMC2692140 SCOPUS ID: 2-s2.0-63749128979 04/14/2009 22 Citations

Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. (Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):589-96 PMID: 19361751 PMCID: PMC2688780 SCOPUS ID: 2-s2.0-63749091853 04/14/2009 28 Citations

Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. (Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, Farinha N, Filopovich A, Fischer A, Friedrich W, Gennery A, Heilmann C, Landais P, Horwitz M, Porta F, Sedlacek P, Seger R, Slatter M, Teague L, Eapen M, Veys P) Pediatrics 2009 Mar;123(3):836-40 PMID: 19255011 PMCID: PMC3380632 SCOPUS ID: 2-s2.0-63149138368 03/04/2009 112 Citations

Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. (Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S) Pediatrics 2009 Mar;123(3):1011-7 PMID: 19255033 PMCID: PMC3120215 SCOPUS ID: 2-s2.0-63149124868 03/04/2009 48 Citations

Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM) Bone Marrow Transplant 2009 Mar;43(6):435-46 PMID: 19182830 SCOPUS ID: 2-s2.0-63949083153 02/03/2009 26 Citations

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. (Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, Shearer WT) J Allergy Clin Immunol 2008 Dec;122(6):1087-96 PMID: 18992926 PMCID: PMC3357108 SCOPUS ID: 2-s2.0-57149131532 11/11/2008 64 Citations

Variation in supportive care practices in hematopoietic cell transplantation. (Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR Jr, Bevans M, Soiffer RJ, Joffe S) Biol Blood Marrow Transplant 2008 Nov;14(11):1231-8 PMID: 18940677 PMCID: PMC3304538 SCOPUS ID: 2-s2.0-53749104934 10/23/2008 55 Citations

HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-1147 PMID: 18804044 PMCID: PMC2581414 SCOPUS ID: 2-s2.0-51649094272 09/23/2008 67 Citations

Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. (Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, Kapoor N, Kernan NA, Rosenthal J, Smith FO, Eapen M) J Clin Oncol 2008 Sep 10;26(26):4326-32 PMID: 18779619 PMCID: PMC2653120 SCOPUS ID: 2-s2.0-52049117651 09/10/2008 50 Citations

Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective. (Eapen M, Rocha V) Lifetime Data Anal 2008 Dec;14(4):379-88 PMID: 18607725 SCOPUS ID: 2-s2.0-55949106080 07/09/2008 11 Citations

Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. (McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R) Transfusion 2008 Sep;48(9):2008-25 PMID: 18564401 SCOPUS ID: 2-s2.0-51049108550 06/20/2008 26 Citations

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. (Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ, Kamani NR, Kurian S, Kapoor N, Ringdén O, Eapen M) Bone Marrow Transplant 2008 Aug;42(3):175-80 PMID: 18454181 SCOPUS ID: 2-s2.0-50049118882 05/06/2008 98 Citations

Individual physician practice variation in hematopoietic cell transplantation. (Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR Jr, Soiffer RJ, Eapen M) J Clin Oncol 2008 May 01;26(13):2162-70 PMID: 18378566 SCOPUS ID: 2-s2.0-43749091065 04/02/2008 47 Citations

Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. (Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, Woolfrey A, Kamani N) Br J Haematol 2008 Apr;141(2):216-23 PMID: 18307564 PMCID: PMC3164958 SCOPUS ID: 2-s2.0-40949092342 03/01/2008 48 Citations

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72 PMID: 18246113 PMCID: PMC3164955 SCOPUS ID: 2-s2.0-44449153972 02/05/2008 25 Citations

State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. (Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program) Biol Blood Marrow Transplant 2008 Jan;14(1):1-6 PMID: 18158954 SCOPUS ID: 2-s2.0-37349091178 12/27/2007 69 Citations

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 PMID: 18033318 SCOPUS ID: 2-s2.0-39149090347 11/23/2007 50 Citations

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 SCOPUS ID: 2-s2.0-36048969811 11/21/2007 167 Citations

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. (Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C) Blood 2007 Dec 15;110(13):4576-83 PMID: 17785583 SCOPUS ID: 2-s2.0-37349118061 09/06/2007 1173 Citations

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. (Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE) Lancet 2007 Jun 09;369(9577):1947-54 PMID: 17560447 SCOPUS ID: 2-s2.0-34249899377 06/15/2007 727 Citations

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. (Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M) Blood 2007 Aug 15;110(4):1397-400 PMID: 17475907 PMCID: PMC1939910 SCOPUS ID: 2-s2.0-34548050458 05/04/2007 265 Citations

Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 PMID: 17459050 SCOPUS ID: 2-s2.0-34247858963 04/27/2007 161 Citations

Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia. (Mehta PA, Eapen M, Klein JP, Gandham S, Elliott J, Zamzow T, Combs M, Aplenc R, MacMillan ML, Weisdorf DJ, Petersdorf E, Davies SM) Br J Haematol 2007 Apr;137(2):152-7 PMID: 17391495 PMCID: PMC2914502 SCOPUS ID: 2-s2.0-33947527879 03/30/2007 16 Citations

Hematopoietic cell transplantation for Chediak-Higashi syndrome. (Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J, Steward CG, Veys PA, Filipovich AH) Bone Marrow Transplant 2007 Apr;39(7):411-5 PMID: 17293882 SCOPUS ID: 2-s2.0-33947625671 02/13/2007 103 Citations

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5 PMID: 17272503 PMCID: PMC1885491 SCOPUS ID: 2-s2.0-34248376573 02/03/2007 167 Citations

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. (Wade JA, Hurley CK, Takemoto SK, Thompson J, Davies SM, Fuller TC, Rodey G, Confer DL, Noreen H, Haagenson M, Kan F, Klein J, Eapen M, Spellman S, Kollman C) Blood 2007 May 01;109(9):4064-70 PMID: 17202313 PMCID: PMC1874562 SCOPUS ID: 2-s2.0-34247387564 01/05/2007 46 Citations

Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. (Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD) Blood 2007 Mar 01;109(5):2256-62 PMID: 17038525 PMCID: PMC1801062 SCOPUS ID: 2-s2.0-33847349880 10/14/2006 173 Citations

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 SCOPUS ID: 2-s2.0-33845478320 09/02/2006 147 Citations

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. (Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM, KIR Study Group, Center for International Blood and Marrow Transplantation Research) Biol Blood Marrow Transplant 2006 Aug;12(8):876-84 PMID: 16864058 SCOPUS ID: 2-s2.0-33746096999 07/26/2006 225 Citations

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 PMID: 16493003 PMCID: PMC1895819 SCOPUS ID: 2-s2.0-33745080964 02/24/2006 142 Citations

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID: 16489361 SCOPUS ID: 2-s2.0-33645240407 02/21/2006 104 Citations

Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 01;24(1):145-51 PMID: 16382124 SCOPUS ID: 2-s2.0-33644834712 12/31/2005 78 Citations

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. (Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr) Biol Blood Marrow Transplant 2005 Dec;11(12):988-98 PMID: 16338621 SCOPUS ID: 2-s2.0-28744450153 12/13/2005 11 Citations

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. (Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA) Bone Marrow Transplant 2006 Jan;37(2):135-41 PMID: 16273115 SCOPUS ID: 2-s2.0-30944438521 11/08/2005 16 Citations

Bone marrow transplantation for diamond-blackfan anemia. (Roy V, Pérez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R, Mustafa MM, Bredeson CN, Non-Malignant Marrow Disorders Working Committee of the International Bone Marrow Transplant Registry) Biol Blood Marrow Transplant 2005 Aug;11(8):600-8 PMID: 16041310 SCOPUS ID: 2-s2.0-22344441866 07/26/2005 62 Citations

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 SCOPUS ID: 2-s2.0-20144389335 12/16/2004 83 Citations

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75 PMID: 15564543 SCOPUS ID: 2-s2.0-9244256765 11/27/2004 995 Citations

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. (Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, Wagner JE) J Clin Oncol 2004 Dec 15;22(24):4872-80 PMID: 15520055 SCOPUS ID: 2-s2.0-16644379996 11/03/2004 234 Citations

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID: 15365077 SCOPUS ID: 2-s2.0-4644343739 09/15/2004 17 Citations

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID: 15322568 SCOPUS ID: 2-s2.0-6444220659 08/24/2004 211 Citations

Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 SCOPUS ID: 2-s2.0-0142023889 10/11/2003 75 Citations

Bullous acral erythema secondary to high-dose methotrexate. (Morrell DS, Challgren E, Eapen M, Esterly NB) J Pediatr Hematol Oncol 2002;24(3):240 PMID: 11990316 SCOPUS ID: 2-s2.0-0036214410 05/07/2002 17 Citations

Late outcomes after bone marrow transplant for aplastic anaemia. (Eapen M, Ramsay NK, Mertens AC, Robison LL, DeFor T, Davies SM) Br J Haematol 2000 Dec;111(3):754-60 PMID: 11122134 SCOPUS ID: 2-s2.0-0034492317 12/21/2000 29 Citations

Massive splenomegaly and Epstein-Barr virus-associated infectious mononucleosis in a patient with Gaucher disease. (Eapen M, Hostetter M, Neglia JP) J Pediatr Hematol Oncol 1999;21(1):47-9 PMID: 10029812 SCOPUS ID: 2-s2.0-0032995288 02/25/1999 10 Citations

Late graft rejection and second infusion of bone marrow in children with aplastic anaemia. (Eapen M, Davies SM, Ramsay NK) Br J Haematol 1999 Jan;104(1):186-8 PMID: 10027732 SCOPUS ID: 2-s2.0-0032587501 02/23/1999 16 Citations

Hematopoietic stem cell transplantation for infantile osteopetrosis. (Eapen M, Davies SM, Ramsay NK, Orchard PJ) Bone Marrow Transplant 1998 Nov;22(10):941-6 PMID: 9849690 SCOPUS ID: 2-s2.0-0031722668 12/16/1998 38 Citations

Last update: 08/17/2026

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Mary Eapen MBChB, MS

Professor

Publications (233)